XML 44 R30.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segment Reporting (Tables)
 6 Months Ended
Jun. 30, 2018
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
Financial information relating to our reportable operating segments and reconciliations to the consolidated totals for the three and six-month periods ended June 30, 2018 and 2017, are as follows (in thousands):

 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2018
 
2017
 
2018
 
2017
Net Sales (1)
 

 
 

 
 

 
 

Cardiovascular
$
216,387

 
$
179,663

 
$
412,241

 
$
344,418

Endoscopy
8,423

 
6,886

 
15,603

 
13,200

Total net sales
$
224,810

 
$
186,549

 
$
427,844

 
$
357,618

 
 
 
 
 
 
 
 
Operating Income (1)
 
 
 
 
 
 
 
Cardiovascular
$
12,663

 
$
11,493

 
$
19,060

 
$
15,475

Endoscopy
2,451

 
1,869

 
4,835

 
3,496

Total operating income
$
15,114

 
$
13,362

 
$
23,895

 
$
18,971


(1) Sales and operating income have been adjusted from prior disclosure to reflect changes in product classifications between our operating segments, which were made to be consistent with updates in the management of our product portfolios in 2018.